Impact of Alprazolam in Allostatic Load and Neurocognition of Patients with Anxiety Disorders and Chronic Stress (GEMA): Observational Study Protocol

Overview

Journal BMJ Open

Specialty General Medicine

Date 2015 Jul 16

PMID 26173716

Citations 2

Authors

Carlos A Soria

Carolina Remedi

Daniel A Nunez

Luciana DAlessio

Emilio J A Roldan

Affiliations

Soon will be listed here.

Abstract

Introduction: The allostatic load model explains the additive effects of multiple biological processes that accelerate pathophysiology related to stress, particularly in the central nervous system. Stress-related mental conditions such as anxiety disorders and neuroticism (a well-known stress vulnerability factor), have been linked to disturbances of hypothalamo-pituitary-adrenal with cognitive implications. Nevertheless, there are controversial results in the literature and there is a need to determine the impact of the psychopharmacological treatment on allostatic load parameters and in cognitive functions. Gador study of Estres Modulation by Alprazolam, aims to determine the impact of medication on neurobiochemical variables related to chronic stress, metabolic syndrome, neurocognition and quality of life in patients with anxiety, allostatic load and neuroticism.

Methods/analysis: In this observational prospective phase IV study, highly sympthomatic patients with anxiety disorders (six or more points in the Hamilton-A scale), neuroticism (more than 18 points in the Neo five personality factor inventory (NEO-FFI) scale), an allostatic load (three positive clinical or biochemical items at Crimmins and Seeman criteria) will be included. Clinical variables of anxiety, neuroticism, allostatic load, neurobiochemical studies, neurocognition and quality of life will be determined prior and periodically (1, 2, 4, 8, and 12 weeks) after treatment (on demand of alprazolam from 0.75 mg/day to 3.0 mg/day). A sample of n=55/182 patients will be considered enough to detect variables higher than 25% (pretreatment vs post-treatment or significant correlations) with a 1-ß power of 0-80. t Test and/or non-parametric test, and Pearson's test for correlation analysis will be determined.

Ethics And Dissemination: This study protocol was approved by an Independent Ethics Committee of FEFyM (Foundation for Pharmacological Studies and Drugs, Buenos Aires) and by regulatory authorities of Argentina (ANMAT, Dossier # 61 409-8 of 20 April 2009), following the law of Habeas Data and psychotherapeutic drug control.

Trial Registration Number: GEMA 20811.

Citing Articles

Reducing Allostatic Load in Depression and Anxiety Disorders: Physical Activity and Yoga Practice as Add-On Therapies.

DAlessio L, Korman G, Sarudiansky M, Guelman L, Scevola L, Pastore A Front Psychiatry. 2020; 11:501.

PMID: 32581876 PMC: 7287161. DOI: 10.3389/fpsyt.2020.00501.

Walking the Tightrope: A Proposed Model of Chronic Pain and Stress.

Lunde C, Sieberg C Front Neurosci. 2020; 14:270.

PMID: 32273840 PMC: 7113396. DOI: 10.3389/fnins.2020.00270.

References

Zemishlany Z, McQueeney R, Gabriel S, Davidson M . Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects. Neuropsychobiology. 1990; 23(3):124-8. DOI: 10.1159/000119437. View

Pomara N, Willoughby L, Ritchie J, Sidtis J, Greenblatt D, Nemeroff C . Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance. Psychopharmacology (Berl). 2005; 182(3):414-9. DOI: 10.1007/s00213-005-0088-2. View

Vasa R, Pine D, Masten C, Vythilingam M, Collin C, Charney D . Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults. Psychopharmacology (Berl). 2009; 204(3):445-55. PMC: 2740930. DOI: 10.1007/s00213-009-1475-x. View

Allard J, Artero S, Ritchie K . Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry. 2003; 18(10):874-8. DOI: 10.1002/gps.891. View

Karege F, Bovier P, Gaillard J, Tissot R . The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients. Acta Psychiatr Scand. 1989; 80(5):499-504. DOI: 10.1111/j.1600-0447.1989.tb03012.x. View

Sanford L, Nassar P, Ross R, Schulkin J, Morrison A . Prolactin microinjections into the amygdalar central nucleus lead to decreased NREM sleep. Sleep Res Online. 2001; 1(3):109-13. View

Garcia-Banda G, Chellew K, Fornes J, Perez G, Servera M, Evans P . Neuroticism and cortisol: pinning down an expected effect. Int J Psychophysiol. 2013; 91(2):132-8. DOI: 10.1016/j.ijpsycho.2013.12.005. View

Heaney J, Phillips A, Carroll D . Ageing, depression, anxiety, social support and the diurnal rhythm and awakening response of salivary cortisol. Int J Psychophysiol. 2010; 78(3):201-8. DOI: 10.1016/j.ijpsycho.2010.07.009. View

McEwen B, Gianaros P . Stress- and allostasis-induced brain plasticity. Annu Rev Med. 2010; 62:431-45. PMC: 4251716. DOI: 10.1146/annurev-med-052209-100430. View

10.

Wong M, Kling M, Munson P, Listwak S, Licinio J, Prolo P . Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A. 2000; 97(1):325-30. PMC: 26662. DOI: 10.1073/pnas.97.1.325. View

11.

Bergson C, Mrzljak L, Smiley J, Pappy M, Levenson R, Goldman-Rakic P . Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci. 1995; 15(12):7821-36. PMC: 6577925. View

12.

Crimmins E, Johnston M, Hayward M, Seeman T . Age differences in allostatic load: an index of physiological dysregulation. Exp Gerontol. 2003; 38(7):731-4. DOI: 10.1016/s0531-5565(03)00099-8. View

13.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

14.

Juster R, McEwen B, Lupien S . Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2009; 35(1):2-16. DOI: 10.1016/j.neubiorev.2009.10.002. View

15.

Sheline Y, Sanghavi M, Mintun M, Gado M . Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999; 19(12):5034-43. PMC: 6782668. View

16.

Yaffe K, Boustani M . Benzodiazepines and risk of Alzheimer's disease. BMJ. 2014; 349:g5312. DOI: 10.1136/bmj.g5312. View

17.

Seeman T, Epel E, Gruenewald T, Karlamangla A, McEwen B . Socio-economic differentials in peripheral biology: cumulative allostatic load. Ann N Y Acad Sci. 2010; 1186:223-39. DOI: 10.1111/j.1749-6632.2009.05341.x. View

18.

Muscettola G, Potter W, Pickar D, Goodwin F . Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings. Arch Gen Psychiatry. 1984; 41(4):337-42. DOI: 10.1001/archpsyc.1984.01790150027005. View

19.

Sultan S, Gebara E, Moullec K, Toni N . D-serine increases adult hippocampal neurogenesis. Front Neurosci. 2013; 7:155. PMC: 3756301. DOI: 10.3389/fnins.2013.00155. View

20.

Abelson J, Curtis G, Cameron O . Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol. J Psychiatr Res. 1996; 30(2):79-93. DOI: 10.1016/0022-3956(95)00035-6. View